Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

CONTEXT: Patients with von Hippel-Lindau (VHL) syndrome have a 25–30% chance of developing pheochromocytoma. Although practice guidelines recommend biochemical and radiological screening every 1–2 years for pheochromocytoma in patients with VHL, there are limited data on the optimal age and frequenc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Aufforth, Rachel D., Ramakant, Pooja, Sadowski, Samira M., Mehta, Amit, Trebska-McGowan, Katarzyna, Nilubol, Naris, Pacak, Karel, Kebebew, Electron
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667160/
https://ncbi.nlm.nih.gov/pubmed/26451910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-3045
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars